ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: For instance, Marin et al. [37] quantitated BCR-ABL expression by real-time PCR in peripheral blood in 161 patients who had initiated imatinib therapy early after diagnosis of CML in CP and who had achieved CCyR.